P/B
2,1
Dolby Laboratories
Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.
Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.
$5.5B
Market Cap • 10/2/2026
1967
(59 years)
Founded
2005
(21 years ago)
IPO
NYSE
Listing Exchange
United States
Country
Valuation
P/S
4,1
P/EBITDA
16,6
P/OCF
12,6
P/FCF
14
P/E
25,1
BVPS
27,6
EPS
2,4
Market Cap
Market Cap
5,5B
EV
4,9B
EV/Revenue
3,6
EV/EBITDA
14,8
EV/EBIT
20,5
Payout
Dividend Per Share
1,4
Dividend Yield
2,4%
Buyback Yield
4,4%
Total Yield
6,8%
Dividend Yield 5Y
2%
Payout
59,4%
Retained Earnings
2,6B
Profitability
Gross Margin
87,6%
EBITDA Margin
24,5%
EBIT Margin
17,7%
Net Margin
16,8%
D&A/EBITDA
0%
R&D/Revenue
19,6%
Capex/Revenue
3,3%
Capex/D&A
48,4%
Capex/OCF
10,3%
SBC/OCF
29,7%
% PPE
15,9%
% Goodwill
16,7%
ROE
8,8%
ROIC
9,4%
Growth
CAGR Revenue 5Y
1,3%
CAGR Op. Income 5Y
-6,5%
CAGR Net Income 5Y
-5,4%
CAGR EPS 5Y
-3,5%
CAGR OCF 5Y
-0,6%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
3,2
Quick Ratio
2,8
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!